Search hospitals > New York > Albany
Women's Cancer Care Associates, LLC
Claim this profileAlbany, New York 12208
Global Leader in Ovarian Cancer
Global Leader in Cancer
Conducts research for Fallopian Tube Cancer
Conducts research for Adenocarcinoma
Conducts research for Ovarian Tumors
53 reported clinical trials
4 medical researchers
Summary
Women's Cancer Care Associates, LLC is a medical facility located in Albany, New York. This center is recognized for care of Ovarian Cancer, Cancer, Fallopian Tube Cancer, Adenocarcinoma, Ovarian Tumors and other specialties. Women's Cancer Care Associates, LLC is involved with conducting 53 clinical trials across 75 conditions. There are 4 research doctors associated with this hospital, such as Emese Zsiros, JOYCE BARLIN, Shashikant B. Lele, and Peter Frederick, MD.Area of expertise
1Ovarian Cancer
Global LeaderStage IV
Stage III
Stage II
2Cancer
Global LeaderStage III
Stage IV
Stage II
Top PIs
Emese ZsirosRoswell Park Cancer Institute3 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
10 reported clinical trials
17 drugs studied
JOYCE BARLINWomens Cancer Care Associates1 year of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
8 reported clinical trials
16 drugs studied
Shashikant B. LeleRoswell Park Cancer Institute5 years of reported clinical research
Studies Adenocarcinoma
Studies Cancer
8 reported clinical trials
18 drugs studied
Peter Frederick, MDRoswell Park1 year of reported clinical research
Studies Endometrial Cancer
Studies Serous Cystadenocarcinoma
4 reported clinical trials
15 drugs studied
Clinical Trials running at Women's Cancer Care Associates, LLC
Ovarian Cancer
Fallopian Tube Cancer
Ovarian Carcinoma
Ovarian Tumors
Peritoneal Cancer
Serous Cystadenocarcinoma
Adenocarcinoma
Peritoneal Tumors
Endometrial Cancer
Fallopian Tube Serous Adenocarcinoma
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
ONC-392 + Pembrolizumab
for Ovarian Cancer
This is a study to test the safety and efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian cancer patients.
Recruiting2 awards Phase 212 criteria
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Women's Cancer Care Associates, LLC?
Women's Cancer Care Associates, LLC is a medical facility located in Albany, New York. This center is recognized for care of Ovarian Cancer, Cancer, Fallopian Tube Cancer, Adenocarcinoma, Ovarian Tumors and other specialties. Women's Cancer Care Associates, LLC is involved with conducting 53 clinical trials across 75 conditions. There are 4 research doctors associated with this hospital, such as Emese Zsiros, JOYCE BARLIN, Shashikant B. Lele, and Peter Frederick, MD.